Clarivate PLC
CLVT3.620USD
-0.230-5.97%
Fechamento 08/01, 16:00（ET）Cotações atrasadas em 15 min
2.43BValor de mercado
PerdaP/L TTM
Mais detalhes de Clarivate PLC Empresa
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It is also engaged in providing comprehensive and integrated solutions to support patent preparation, filing and prosecution, offering patent practitioners with automation and artificial intelligence (AI)-enabled solutions.
Informações da empresa
Código da empresaCLVT
Nome da EmpresaClarivate PLC
Data de listagemOct 29, 2018
Fundado em2019
CEOMr. Matitiahu Shem (Matti) Tov
Número de funcionários12000
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 29
Endereço70 St. Mary Axe
CidadeLONDON
Bolsa de valoresNYSE Consolidated
PaísUnited Kingdom
Código postalEC3A 8BE
Telefone442074334000
Sitehttps://clarivate.com/
Código da empresaCLVT
Data de listagemOct 29, 2018
Fundado em2019
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
729.15K
+150.40%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
488.98K
+10.04%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
411.80K
-8.81%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
116.52K
+42.06%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
101.81K
+41.73%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+57.91%
Mr. Kenneth L. Cornick
Mr. Kenneth L. Cornick
Director
Director
29.95K
--
Mr. Jane Okun Bomba, CPA
Mr. Jane Okun Bomba, CPA
Independent Director
Independent Director
--
--
Ms. Suzanne Heywood
Ms. Suzanne Heywood
Independent Director
Independent Director
--
--
Mr. Usama N. Cortas
Mr. Usama N. Cortas
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
729.15K
+150.40%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
488.98K
+10.04%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
411.80K
-8.81%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
116.52K
+42.06%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
101.81K
+41.73%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+57.91%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Subscription revenues
388.60M
65.45%
Re-occurring revenues
105.90M
17.84%
Transactional revenues
99.20M
16.71%
Por RegiãoUSD
Nome
Receita
Proporção
Americas
321.10M
54.08%
Europe/ Middle East /Africa
151.70M
25.55%
Asia Pacific
120.90M
20.36%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Subscription revenues
388.60M
65.45%
Re-occurring revenues
105.90M
17.84%
Transactional revenues
99.20M
16.71%
Distribuição de ações
Atualizado em: qua, 2 de jul
Atualizado em: qua, 2 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Leonard Green & Partners, L.P.
17.36%
Clarkston Capital Partners, LLC
11.09%
Giovanni Agnelli B V
10.01%
Impactive Capital LP
6.40%
Onex Corporation
6.24%
Other
48.91%
Investidores
Investidores
Proporção
Leonard Green & Partners, L.P.
17.36%
Clarkston Capital Partners, LLC
11.09%
Giovanni Agnelli B V
10.01%
Impactive Capital LP
6.40%
Onex Corporation
6.24%
Other
48.91%
Tipos de investidores
Investidores
Proporção
Private Equity
30.46%
Investment Advisor
29.45%
Hedge Fund
14.74%
Investment Advisor/Hedge Fund
12.61%
Holding Company
9.85%
Corporation
5.58%
Pension Fund
1.75%
Individual Investor
1.03%
Sovereign Wealth Fund
0.85%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
647
749.14M
111.46%
-141.21M
2025Q1
695
750.51M
109.86%
-167.62M
2024Q4
712
766.77M
110.84%
-166.20M
2024Q3
726
765.53M
108.25%
-158.23M
2024Q2
741
760.08M
105.78%
-120.39M
2024Q1
752
730.14M
108.67%
-137.39M
2023Q4
783
725.50M
108.90%
-179.38M
2023Q3
791
741.16M
111.25%
-79.71M
2023Q2
796
712.25M
105.35%
-100.17M
2023Q1
777
702.68M
104.01%
-43.46M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Leonard Green & Partners, L.P.
116.67M
17.08%
--
--
Mar 31, 2025
Clarkston Capital Partners, LLC
74.53M
10.91%
+3.79M
+5.36%
Mar 31, 2025
Giovanni Agnelli B V
67.29M
9.85%
--
--
Mar 31, 2025
Impactive Capital LP
43.03M
6.3%
--
--
Mar 31, 2025
Onex Corporation
41.92M
6.14%
-938.25K
-2.19%
Mar 10, 2025
Selige Co-Investor Pooling SCSp
38.09M
5.58%
--
--
Mar 10, 2025
Partners Group AG
25.58M
3.75%
--
--
Mar 31, 2025
Cambridge Information Group, Inc.
23.90M
3.5%
+290.94K
+1.23%
Mar 10, 2025
Dimensional Fund Advisors, L.P.
16.59M
2.43%
+2.13M
+14.75%
Mar 31, 2025
Fidelity Investments Canada ULC
16.19M
2.37%
+902.39K
+5.90%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: há 11 horas
Atualizado em: há 11 horas
Nome
Proporção
AGF US Market Neutral Anti-Beta Fund
0.52%
First Trust Technology Alphadex
0.31%
Avantis US Small Cap Value ETF
0.2%
WisdomTree US MidCap Fund
0.19%
JPMorgan US Value Factor ETF
0.18%
DFA Dimensional US Small Cap Value ETF
0.16%
John Hancock Multifactor Small Cap ETF
0.14%
Nuveen ESG Small-Cap ETF
0.13%
BNY Mellon US Small Cap Core Equity ETF
0.09%
Strive Small-Cap ETF
0.08%
Ver Mais
AGF US Market Neutral Anti-Beta Fund
Proporção0.52%
First Trust Technology Alphadex
Proporção0.31%
Avantis US Small Cap Value ETF
Proporção0.2%
WisdomTree US MidCap Fund
Proporção0.19%
JPMorgan US Value Factor ETF
Proporção0.18%
DFA Dimensional US Small Cap Value ETF
Proporção0.16%
John Hancock Multifactor Small Cap ETF
Proporção0.14%
Nuveen ESG Small-Cap ETF
Proporção0.13%
BNY Mellon US Small Cap Core Equity ETF
Proporção0.09%
Strive Small-Cap ETF
Proporção0.08%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
